
Please try another search
(Reuters) -Thermo Fisher Scientific Inc raised its full-year 2021 outlook, boosted by revenue from its life sciences unit which makes raw materials for COVID-19 vaccine production and strong demand for its analytical instruments.
The world's largest maker of scientific instruments has benefited as one of the major providers of coronavirus tests to governments and healthcare providers during the pandemic.
The company is betting on sustained demand for raw materials to help blunt the blow from a widely expected slowdown in COVID-19 testing as vaccinations gain steam worldwide.
Revenue at Thermo Fisher (NYSE:TMO)'s life sciences unit grew 37% to $3.56 billion in the second quarter. The company said it generated COVID-19 response revenue of $1.9 billion in the quarter.
The company raised its 2021 revenue forecast by $300 million to $35.90 billion and now expects adjusted profit of $22.07 per share, compared to its previous forecast of $21.97 per share.
Its net income rose to $1.83 billion, or $4.61 per share, for the quarter ended July 3, from $1.16 billion, or $2.90 per share, a year earlier.
(Reuters) - Flexible workspace provider WeWork Inc on Thursday appointed Andre Fernandez as its chief financial officer (CFO), replacing Benjamin Dunham. Fernandez, who most...
By Bianca Flowers and Joseph White BONDURANT, Iowa (Reuters) - Deere (NYSE:DE) & Co has sold its tractors and other equipment to farmers for decades, but the world's largest...
By Nichola Saminather TORONTO (Reuters) -Royal Bank of Canada, Toronto-Dominion Bank and Canadian Imperial Bank of Commerce (CIBC) reported diverging second-quarter performances...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.